InteractionsGuide Index Page

 
Case Analysis Toolclose
Enter Each Substance:


Analysis Search Terms:

Aloe

Botanical Name: Aloe vera (L.) Burm.
Pharmacopoeial Name: Aloe vera gel.
Synonym: Aloe barbadensis (Mill.).
Common Names: Aloe gel, aloe vera gel.

Summary Table
herb description

Family

Aloaceae (formerly in Liliaceae).

Related Species

Aloe ferox Mill., A. africana Mill., A. spicata Baker., A. perryi Baker.; the Aloe genus has more than 300 species. Aloe vera has been widely hybridized in commerce, and cultivars are the primary source of the gel.

Habitat and Cultivation

Native to Africa, widespread in cultivation throughout subtropical regions in North and South America, West Indies, and East Asia; the cactuslike aloe is also a popular houseplant.

Parts Used

Aloe gel is a mucilaginous, colorless liquid derived from the central parenchymatous cells of the fresh leaves of aloe.

Note: Aloe gel and aloe latex are completely distinct remedies. The anthraquinone-containing dried juice, a yellow-orange latex, or sap exuded from the outer or pericycle (vascular bundles) area of the leaf, is often known as “Cape aloe” or “Curacao aloe.” Some traditional cultures have used the root as a medicine, but this is not a current Western usage. Aloe latex can be considered with the Rhamnacae species such as cascara ( Rhamnus purshiana DC), the buckthorns ( R. frangula L. and R. cathartica L.), as well as senna leaf and fruits ( Cassia senna L.) and rhubarb root ( Rheum palmatum L.). All these species contain closely related anthraquinone glycosides that dominate their pharmacology, particularly the pronounced laxative and purgative activity associated with these herbs.

Common Forms

100% Fresh gel and freeze-dried concentrates, typically 4.5:1 concentrate, equivalent to 11.25 mg/mL of acemannan.

  • Standardized Extracts:   Preparations based on acemannan (acetylated mannose polysaccharide) obtained by hydroethanolic extraction from the inner leaf gel. Multiple proprietary products are available, including Carrysyn (73% acemannan, Carrington Laboratories).

Note: “Aloe juice” is not a pharmacopoeial term; it describes varied products sold commercially that contain diluted gel. These products may contain only small amounts of the active gel constituents and may incorporate added thickeners such as pectins and starch. These juice products are usually anthraquinone free.

herb in clinical practice

Overview

Aloe vera gel, the clear, colorless mucilage from the central parenchyma of the leaf, is primarily known for promoting topical healing of burns, wounds, incisions, frostbite, ulcers, and related inflammatory problems. The gel is also widely incorporated into natural cosmetic and skin care products. Modern research interest has focused on identifying the active polysaccharide components of the gel and investigating their potential immunomodulatory properties as biological response modifiers. 1 Internal applications are also of interest, such as for inflammatory bowel disease, and a positive trial in active ulcerative colitis patients is available. 2,3

Proprietary aloe extracts based on hydrogel are available in professional and consumer markets. These are either stabilized by means of rapid pasteurization or freeze-dried as a soluble powder; both forms contain standardized amounts of the main active polysaccharide (acemannan). Professional products are available in a variety of applications for wound care, burn treatment, diabetic care, general first-aid dressings, and management of radiation and chemotherapy adverse effects. Limited clinical evidence supports these applications, although promotion of wound healing appears to be better supported by the available data than burn treatment.

In the United States, popular dietary supplement products combining freeze-dried acemannan with other ingredients are “network marketed” as “glyconutritionals.” These are promoted as nonspecific immunostimulants, often with wide-ranging therapeutic claims, including for the treatment of cancer and human immunodeficiency virus (HIV). Evidence for such claims is not substantial at this time and is partly extrapolated from non–peer-reviewed data supplied to the U.S. Patent Office based on in vitro or uncontrolled animal studies using parenteral routes of administration. 4

Aloe gel and its derivative products are not officially approved for internal medical use, although some proprietary topical hydrogel products have been approved by the U.S. Food and Drug Administration (FDA). The botanical literature emphasizes the anthraquinone herb rather than the gel. The World Health Organization (WHO) monograph series includes both remedies separately, but this is the exception. 5 Comprehensive literature reviews relating to recent immunological research on the gel are unavailable, although there are surveys of the data up to the late 1990s. 6 The available clinical trial evidence on aloe gel extracts was systematically reviewed in 1999 by Vogler and Ernst. 7

Historical/Ethnomedicine Precedent

Aloe leaf has been in recorded use for centuries, with documentation by Dioscorides, Pliny, and Galen, as well as in traditional Ayurvedic and Chinese medicine. The gel was allegedly used by Cleopatra for cosmetic skin enhancement, but Europeans became more familiar with uses of the gel from African tribes and subsequently planted specimens of Aloe spp. throughout their colonies, which became rapidly naturalized in subtropical zones. Aloe spread in the United States, especially Florida, where it was used by the Seminole people for healing burns and stings. The gel remains in widespread popular folk use; currently it is often kept as a houseplant, with a leaf cut to obtain fresh gel as treatment for sunburn, thermal burns, insect bite, and other first-aid needs.

Known or Potential Therapeutic Uses

  • External/Topical:   Treatment of abscesses, burns, surgical incisions, wounds, ulcers (oral, leg), dermatitis, and psoriasis.

  • Internal:   Antiviral (HIV/herpes simplex virus [HSV]), dysglycemia, inflammatory bowel disease, immunomodulation, peptic ulcer preventive, ulcerative colitis.

Key Constituents

The gel is more than 97% water by weight. The solid matter is approximately 65% carbohydrate, predominantly in the form of a long-chained, polydispersed, beta-(1,4)-acetylated mannan (acemannan). 8,9Sterols, organic acids (especially oxalate), and various amino acids make up the remainder. Novel dihydrocoumarins have recently been described. 10 Naturally occurring enzymes are present in the fresh gel, and pasteurization is necessary to stabilize the gel to prevent enzymatic degradation.

Therapeutic Dosing Range

  • Fresh Juice Concentrate:   25 mL up to four times daily.

  • Standardized Extracts:   500 to 800 mg-equivalent acemannan daily.

interactions review

Strategic Considerations

The WHO monograph on aloe gel does not ascribe any interactions involving the herb. 5 The anthraquinone-containing Aloe latex is not considered here, but the reader should refer to the Cascara monograph for some interactions typical of the anthraquinone-containing botanicals.

In the setting of externally applied medications, aloe interactions are limited to various combination preparations, using the hydrogel as a vehicle with related materials (e.g., algal gums, synthetic hydrogels) or as an ingredient of creams and ointments in combination with anti-inflammatory agents.

The topical effects of the gel are thought to be the result of several mechanisms. 11,12Anti-inflammatory effects have been established experimentally in the treatment of adjuvant arthritis, paw edema, frostbite, and diabetic ulceration in animal models, 11,13-15as well as in human mucosal CaCO2cells in vitro. 2 The mechanisms involved are probably multifactorial and include inhibition of prostaglandin synthesis, antioxidant quenching of free radicals, and bradykinin inhibition, as well as promotion of connective tissue development, inhibition of collagenase (and metalloproteinase) activity, and stimulation of cell-mediated immunity. 14,16-21Research at Carrington Laboratories has established that the pectins present in aloe vera gel are efficient stabilizers of peptides, which constitute a large class of tissue growth factors and immunomodulators, and may explain some of the observed activities of the plant gel (by increasing the half-life of peptide cytokines and growth factors). 22

Since the 1930s, when aloe gel was first investigated for the topical treatment of “roentgen dermatitis,” there have been persistent attempts to establish its efficacy for topical treatment of ultraviolet B (UVB) and x-ray radiation burns, although with consistently mixed results. 23 Recent animal tests have been positive, 24 but the only randomized controlled clinical trial available failed to show any benefit of the gel against placebo on chest wall and breast irradiation in 108 breast cancer patients. 25 Another oncological use is in chemotherapy-induced mucositis, although only oral (aphthous stomatitis) treatment has received substantial evidential support, and a proprietary aloe hydrogel product has been FDA approved for aphthous ulcer treatment. 26

Internal use of the gel has been examined in relation to potential antiviral and immunostimulating effects for HIV patients, as well as for glycemic regulation in diabetic patients. Neither of these indications is well supported, nor are they in current general use clinically by practitioners of natural or botanical medicine. Suggestions of potential synergistic interactions with antivirals and antidiabetic agents are discussed later (see Theoretical, Speculative, and Preliminary Interactions Research). A recent United Kingdom trial established positive support for the use of aloe gel internally for ulcerative colitis. 2,3Wide variation in commercial and proprietary processing methods, leading to products with differing activities, may underlie much of the conflicting results in clinical trials in various applications of “stabilized” Aloe vera products. The only relatively uniform activity would be from fresh gel obtained from freshly harvested aloe leaves, which are, however, logistically difficult to use in studies.

One recent, small, crossover-design human trial found a significant effect of aloe on the pharmacokinetics of vitamin C and vitamin E absorption. When single doses of the vitamins were consumed orally with 2 oz of aloe gel or whole-leaf extract, absorption of both the water-soluble and fat-soluble vitamins were significantly slowed, leading to longer half-life in plasma. The authors suggested that aloe could be used to complement the absorption of these nutrients. 27

Data on the effects of aloe gel on drug-metabolizing enzymes and transporters are not available.

herb-drug interactions
Chemotherapy and Radiotherapy Associated with Mucositis, Including Bleomycin, Fluorouracil/5-FU, and Methotrexate
Surgery and Other Wound Care
theoretical, speculative, and preliminary interactions research, including overstated interactions claims
Antivirals: Acyclovir and Related Purine Nucleoside Analog Antivirals; Zidovudine/AZT and Related Reverse-Transcriptase Inhibitor (Nucleoside Analogs and Nonnucleosides) Antiretroviral Agents

Evidence: Acyclovir (Zovirax), zidovudine (azidothymidine, AZT, ZDV, zidothymidine; Retrovir).

Extrapolated, based on similar properties: Zidovudine combination drugs: abacavir (ziager), zidovudine, and lamivudine (Combivir); abacavir (ziager), lamivudine, and zidovudine (Trizivir); didanosine (ddI, dideoxyinosine; Videx), dideoxycytidine (ddC, zalcitabine; Hivid), lamivudine (3TC, Epivir), stavudine (D4T, Zerit), tenofovir (Viread).

A preliminary in vitro study examined the potential synergistic effects of acemannan with both azidothymidine (AZT) and acyclovir on human U1 cells infected with HSV-1 and HIV-1. The investigators found a synergistic antiviral effect in which suboptimal drug doses, when combined with acemannan, produced significant antiviral effects. The authors suggest this should be further investigated as a possibly beneficial clinical interaction for HIV/AIDS patients because the mechanisms of the drug and herb were considered to be mutually exclusive. 43 Only one subsequent trial has investigated the effect of the combination in HIV patients and found no effect of acemannan on CD4 count decline compared with the control groups, which included coadministration with AZT over 48 weeks of treatment. 44

Glyburide and Related Sulfonylurea Hypoglycemics
Hydrocortisone and Related Topical Corticosteroids
Sevoflurane
Citations
  • 1.Leung MY, Liu C, Koon JC, Fung KP. Polysaccharide biological response modifiers. Immunol Lett 2006.View Abstract
  • 2.Langmead L, Feakins RM, Goldthorpe S et al. Randomized, double-blind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis. Aliment Pharmacol Ther 2004;19:739-747.View Abstract
  • 3.Langmead L, Rampton DS. Review article: complementary and alternative therapies for inflammatory bowel disease. Aliment Pharmacol Ther 2006;23:341-349.View Abstract
  • 4.US Patent 5,308,838. Irving, TX: Carrington Laboratories; May 3, 1994.
  • 5.WHO. Aloe. WHO Monographs on Selected Medicinal Plants. 1 vol. Geneva: World Health Organization; 1999:33-42.
  • 6.Reynolds T, Dweck AC. Aloe vera leaf gel: a review update. J Ethnopharmacol 1999;68:3-37.View Abstract
  • 7.Vogler BK, Ernst E. Aloe vera: a systematic review of its clinical effectiveness. Br J Gen Pract 1999;49:823-828.View Abstract
  • 8.Tai-Nin Chow J, Williamson DA, Yates KM, Goux WJ. Chemical characterization of the immunomodulating polysaccharide of Aloe vera L. Carbohydr Res 2005;340:1131-1142.View Abstract
  • 9.Im SA, Oh ST, Song S et al. Identification of optimal molecular size of modified Aloe polysaccharides with maximum immunomodulatory activity. Int Immunopharmacol 2005;5:271-279.View Abstract
  • 10.Zhang X-f, Wang H-m, Song Y-l et al. Isolation, structure elucidation, antioxidative and immunomodulatory properties of two novel dihydrocoumarins from Aloe vera. Bioorg Med Chem Lett 2006;16:949-953.View Abstract
  • 11.Heggers JP, Kucukcelebi A, Listengarten D et al. Beneficial effect of Aloe on wound healing in an excisional wound model. J Altern Complement Med 1996;2:271-277.View Abstract
  • 12.Heggers JP, Elzaim H, Garfield R et al. Effect of the combination of Aloe vera, nitroglycerin, and L-NAME on wound healing in the rat excisional model. J Altern Complement Med 1997;3:149-153.View Abstract
  • 13.Chithra P, Sajithlal GB, Chandrakasan G. Influence of Aloe vera on the glycosaminoglycans in the matrix of healing dermal wounds in rats. J Ethnopharmacol 1998;59:179-186.View Abstract
  • 14.Heggers JP, Robson MC, Manavalen K et al. Experimental and clinical observations on frostbite. Ann Emerg Med 1987;16:1056-1062.View Abstract
  • 15.Muller MJ, Hollyoak MA, Moaveni Z et al. Retardation of wound healing by silver sulfadiazine is reversed by Aloe vera and nystatin. Burns 2003;29:834-836.View Abstract
  • 16.Yagi A, Takeo S. [Anti-inflammatory constituents, aloesin and aloemannan in Aloe species and effects of tanshinon VI in Salvia miltiorrhiza on heart]. Yakugaku Zasshi 2003;123:517-532.View Abstract
  • 17.Bautista-Perez R, Segura-Cobos D, Vazquez-Cruz B. In vitro antibradykinin activity of Aloe barbadensis gel. J Ethnopharmacol 2004;93:89-92.View Abstract
  • 18.Barrantes E, Guinea M. Inhibition of collagenase and metalloproteinases by aloins and aloe gel. Life Sci 2003;72:843-850.View Abstract
  • 19.Ishii Y, Tanizawa H, Takino Y. Studies of aloe. III. Mechanism of cathartic effect. (2). Chem Pharm Bull (Tokyo) 1990;38:197-200.View Abstract
  • 20.Vazquez B, Avila G, Segura D, Escalante B. Antiinflammatory activity of extracts from Aloe vera gel. J Ethnopharmacol 1996;55:69-75.View Abstract
  • 21.Womble D, Helderman JH. Enhancement of allo-responsiveness of human lymphocytes by acemannan (Carrisyn). Int J Immunopharmacol 1988;10:967-974.View Abstract
  • 22.Turner C. Personal communication.
  • 23.Maddocks-Jennings W, Wilkinson JM, Shillington D. Novel approaches to radiotherapy-induced skin reactions: a literature review. Complement Ther Clin Pract 2005;11:224-231.View Abstract
  • 24.Roberts DB, Travis EL. Acemannan-containing wound dressing gel reduces radiation-induced skin reactions in C3H mice. Int J Radiat Oncol Biol Phys 1995;32:1047-1052.View Abstract
  • 25.Williams MS, Burk M, Loprinzi CL et al. Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity. Int J Radiat Oncol Biol Phys 1996;36:345-349.View Abstract
  • 26.Editorial. Oral ulcers remedy gets FDA clearance. J Am Dent Assoc 1994;125:1308, 1310.
  • 27.Vinson JA, Al Kharrat H, Andreoli L. Effect of Aloe vera preparations on the human bioavailability of vitamins C and E. Phytomedicine 2005;12:760-765.View Abstract
  • 28.Peterson DE, Schubert MM. Oral Toxicity. In: Perry M, ed. The Chemotherapy Source Book. 3rd ed. Philadelphia: Lippincott, Williams & Wilkins; 2001:406-424.
  • 29.Garnick JJ, Singh B, Winkley G. Effectiveness of a medicament containing silicon dioxide, aloe, and allantoin on aphthous stomatitis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;86:550-556.View Abstract
  • 30.Borrelli F, Izzo AA. The plant kingdom as a source of anti-ulcer remedies. Phytother Res 2000;14:581-591.View Abstract
  • 31.Suvitayavat W, Sumrongkit C, Thirawarapan SS, Bunyapraphatsara N. Effects of Aloe preparation on the histamine-induced gastric secretion in rats. J Ethnopharmacol 2004;90:239-247.View Abstract
  • 32.Yusuf S, Agunu A, Diana M. The effect of Aloe vera A. Berger (Liliaceae) on gastric acid secretion and acute gastric mucosal injury in rats. J Ethnopharmacol 2004;93:33-37.View Abstract
  • 33.Can A, Akev N, Ozsoy N et al. Effect of Aloe vera leaf gel and pulp extracts on the liver in type-II diabetic rat models. Biol Pharm Bull 2004;27:694-698.View Abstract
  • 34.Dorr W, Schlichting S, Bray MA et al. Effects of dexpanthenol with or without Aloe vera extract on radiation-induced oral mucositis: preclinical studies. Int J Radiat Biol 2005;81:243-250.
  • 35.Heggie S, Bryant GP, Tripcony L et al. A Phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue. Cancer Nurs 2002;25:442-451.View Abstract
  • 36.Richardson J, Smith JE, McIntyre M et al. Aloe vera for preventing radiation-induced skin reactions: a systematic literature review. Clin Oncol (R Coll Radiol) 2005;17:478-484.View Abstract
  • 37.Talmadge J, Chavez J, Jacobs L et al. Fractionation of Aloe vera L. inner gel, purification and molecular profiling of activity. Int Immunopharmacol 2004;4:1757-1773.View Abstract
  • 38.Fulton JE, Jr. The stimulation of postdermabrasion wound healing with stabilized aloe vera gel-polyethylene oxide dressing. J Dermatol Surg Oncol 1990;16:460-467.
  • 39.Fulton JE, Jr. Dermabrasion-Loo-punch-excision technique for the treatment of acne-induced osteoma cutis. J Dermatol Surg Oncol 1987;13:655-659.
  • 40.Schmidt JM, Greenspoon JS. Aloe vera dermal wound gel is associated with a delay in wound healing. Obstet Gynecol 1991;78:115-117.View Abstract
  • 41.Thomas DR, Goode PS, LaMaster K, Tennyson T. Acemannan hydrogel dressing versus saline dressing for pressure ulcers: a randomized, controlled trial. Adv Wound Care 1998;11:273-276.View Abstract
  • 42.Poor MR, Hall JE, Poor AS. Reduction in the incidence of alveolar osteitis in patients treated with the SaliCept patch, containing acemannan hydrogel. J Oral Maxillofac Surg 2002;60:374-379; discussion 379.View Abstract
  • 43.Kahlon JB, Kemp MC, Yawei N et al. In vitro evaluation of the synergistic antiviral effects of acemannan in combination with azidothymidine and acyclovir. Mol Biother 1991;3:214-223.View Abstract
  • 44.Montaner JS, Gill J, Singer J et al. Double-blind placebo-controlled pilot trial of acemannan in advanced human immunodeficiency virus disease. J Acquir Immune Defic Syndr Hum Retrovirol 1996;12:153-157.View Abstract
  • 45.Grover JK, Yadav S, Vats V. Medicinal plants of India with anti-diabetic potential. J Ethnopharmacol 2002;81:81-100.View Abstract
  • 46.Yeh GY, Eisenberg DM, Kaptchuk TJ, Phillips RS. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care 2003;26:1277-1294.View Abstract
  • 47.Brunyapraphatsara N, Yongchaiyuda S, Rungpitarangsi V, Chokechaijaroenporn O. Antidiabetic activity of Aloe vera L juice. II. Clinical trial in diabetes mellitus patients in combination with glibenclamide. Phytomedicine 1996;3:245-248.
  • 48.Brinker F. Herb Contraindications and Drug Interactions. 3rd ed. Sandy, OR: Eclectic Medical Publications; 2001.
  • 49.Chalaprawat M. The hypoglycemic effects of Aloe vera in Thai diabetic patients. J Clin Epidemiol 1997;50:3S.
  • 50.Okyar A, Can A, Akev N et al. Effect of Aloe vera leaves on blood glucose level in type I and type II diabetic rat models. Phytother Res 2001;15:157-161.View Abstract
  • 51.Beppu H, Shimpo K, Chihara T et al. Antidiabetic effects of dietary administration of Aloe arborescens Miller components on multiple low-dose streptozotocin-induced diabetes in mice: investigation on hypoglycemic action and systemic absorption dynamics of aloe components. J Ethnopharmacol 2006;103:468-477.View Abstract
  • 52.Rajasekaran S, Sivagnanam K, Subramanian S. Antioxidant effect of Aloe vera gel extract in streptozotocin-induced diabetes in rats. Pharmacol Rep 2005;57:90-96.View Abstract
  • 53.Davis RH, Parker WL, Murdoch DP. Aloe vera as a biologically active vehicle for hydrocortisone acetate. J Am Podiatr Med Assoc 1991;81:1-9.View Abstract
  • 54.Lee A, Chui PT, Aun CS et al. Possible interaction between sevoflurane and Aloe vera. Ann Pharmacother 2004;38:1651-1654.
  • 55.Dogan IV, Ovali E, Eti Z et al. The in vitro effects of isoflurane, sevoflurane, and propofol on platelet aggregation. Anesth Analg 1999;88:432-436.View Abstract